Skip to main content
. 2020 Sep 30;12(10):2831. doi: 10.3390/cancers12102831
ADT androgen deprivation therapy
AR androgen receptor
EBRT external beam radiation therapy
GM-CSF granulocyte-macrophage colony stimulating factor
GVAX cancer vaccine consisting of whole tumor cells that secrete GM-CSF
IDO indoleamine 2,3 dioxygenase
mCRPC metastatic castration-resistant prostate cancer
MDSC myeloid-derived suppressor cells
MFS metastasis-free survival
NaF sodium fluoride
PAP prostatic acid phosphatase
PROSTVAC prostate cancer vaccine consisting of vaccinia encoding PSA as a primary immunization followed by fowlpox encoding PSA booster immunizations
PSA prostate-specific antigen
PSMA prostate-specific membrane antigen
Sip-T sipuleucel-T, an FDA-approved autologous cellular vaccine for the treatment of prostate cancer
TRAMP transgenic adenocarcinoma of the mouse prostate mouse model
Treg regulatory T cells